Saturday 17 October 2026
Export VINC’s income statement to Excel — free account
Vincerx Pharma, Inc.
VINC Healthcare Biotechnology
In the quarter to March 2025, EPS grew 87.9% and free cash flow grew 42.5%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.02
0.01
−33.33%
Follow VINC
| Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | Jan '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.21 | 2.63 | 6.11 | 6.11 | 8.04 | 8.04 | 1.67 | 1.67 | 0.00 | 0.00 |
Net Debt/EBITDA |
0.17 | 0.30 | 0.74 | 0.75 | 1.79 | 1.79 | 5.78 | 5.77 | 0.00 | 0.00 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.87 | 1.01 | 0.95 | 0.91 | 0.85 | 0.85 | 0.14 | 0.14 | 0.00 | 0.00 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | (15.46) | 0.00 | 0.00 | — | — | — |
| (431.29%) | (136.38%) | (85.12%) | 0.00% | (62.54%) | 0.00% | (131.20%) | 0.00% | 103.45% | 103.45% | |
| (229.38%) | (103.63%) | (71.18%) | 0.00% | (43.46%) | 0.00% | (52.60%) | 0.00% | (9,000.00%) | (9,000.00%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(2,663.77%) | (433.99%) | (134.05%) | (130.61%) | (40.04%) | (38.50%) | (65.70%) | (65.70%) | 102.27% | 102.27% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | 0.00% | — | 0.00% | — | 0.00% | — |
Free Cash Flow per Share |
(13.77) | (37.98) | (56.68) | (2.83) | (45.02) | (1.94) | (8.68) | (0.16) | 0.00 | 0.00 |
Cash per Share |
2.67 | 12.07 | 49.96 | 2.50 | 129.91 | 6.50 | 235.31 | 4.42 | 0.00 | 0.00 |
Shareholders Equity per Share |
1.44 | 10.54 | 45.33 | 2.27 | 116.82 | 5.84 | 96.65 | 1.81 | (0.20) | (0.01) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.44 | 10.54 | 45.33 | 2.27 | 116.82 | 5.84 | 96.65 | 1.81 | (0.20) | (0.01) |
Free Cash Flow |
(26.13) | (40.45) | (59.60) | (59.60) | (38.66) | (33.40) | (2.28) | (2.28) | 0.00 | — |
Working Capital |
1.13 | 9.13 | 46.81 | 46.81 | 97.92 | 97.92 | 25.30 | 25.30 | (0.04) | (0.04) |
Capital Expenditures |
— | — | — | — | (5.26) | (0.26) | 0.00 | — | — | — |
Net Current Asset Value |
1.13 | 7.74 | 44.35 | 44.35 | 94.49 | 94.49 | 25.30 | 25.30 | (0.04) | (0.04) |
| Other line items | ||||||||||
Quick Ratio |
1.16 | 2.48 | 5.89 | 5.89 | 8.02 | 8.02 | 1.63 | 1.63 | 0.00 | 0.00 |
Depreciation/Fixed assets |
0.00 | 2.28 | 3.66 | 0.29 | 1.46 | 0.08 | 0.00 | — | — | — |
Cash ROIC |
(335.39%) | (168.02%) | (59.49%) | (59.49%) | (18.25%) | (15.76%) | (2.61%) | (2.61%) | 0.00% | 0.00% |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | — | — | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | 0.00 | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | 0.00 | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(13.77) | (37.98) | (56.68) | (2.83) | (38.89) | (1.94) | (8.68) | (0.16) | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (6.12) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.04 | 1.21 | 1.37 | — | — | — | — | — | — | — |
Average Payables |
2.26 | 3.28 | 3.04 | 2.54 | 1.26 | 1.26 | 0.26 | 2.76 | 0.04 | 0.04 |
Average Assets |
13.11 | 38.75 | 88.48 | 88.48 | 90.43 | 90.43 | 31.60 | 31.60 | 0.00 | 0.00 |
Average Common Equity |
6.97 | 29.45 | 73.99 | 73.99 | 62.85 | 62.85 | 12.67 | 12.67 | (0.04) | (0.04) |
Capex to Sales |
— | — | — | — | 0.00 | — | 0.00 | — | — | — |
Columns are period end dates